Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Has Walgreen Become the Perfect Stock?

Every investor would love to stumble upon the perfect stock. But will you ever really find a stock that provides everything you could possibly want?

One thing's for sure: You'll never discover truly great investments unless you actively look for them. Let's discuss the ideal qualities of a perfect stock, then decide if Walgreen (NYSE: WAG  ) fits the bill.

The quest for perfection
Stocks that look great based on one factor may prove horrible elsewhere, making due diligence a crucial part of your investing research. The best stocks excel in many different areas, including these important factors:

  • Growth. Expanding businesses show healthy revenue growth. While past growth is no guarantee that revenue will keep rising, it's certainly a better sign than a stagnant top line.
  • Margins. Higher sales mean nothing if a company can't produce profits from them. Strong margins ensure that company can turn revenue into profit.
  • Balance sheet. At debt-laden companies, banks and bondholders compete with shareholders for management's attention. Companies with strong balance sheets don't have to worry about the distraction of debt.
  • Money-making opportunities. Return on equity helps measure how well a company is finding opportunities to turn its resources into profitable business endeavors.
  • Valuation. You can't afford to pay too much for even the best companies. By using normalized figures, you can see how a stock's simple earnings multiple fits into a longer-term context.
  • Dividends. For tangible proof of profits, a check to shareholders every three months can't be beat. Companies with solid dividends and strong commitments to increasing payouts treat shareholders well.

With those factors in mind, let's take a closer look at Walgreen.


What We Want to See


Pass or Fail?

Growth 5-Year Annual Revenue Growth > 15% 8.8% Fail
  1-Year Revenue Growth > 12% 7.1% Fail
Margins Gross Margin > 35% 28.4% Fail
  Net Margin > 15% 3.8% Fail
Balance Sheet Debt to Equity < 50% 16.2% Pass
  Current Ratio > 1.3 1.52 Pass
Opportunities Return on Equity > 15% 18.6% Pass
Valuation Normalized P/E < 20 11.72 Pass
Dividends Current Yield > 2% 2.8% Pass
  5-Year Dividend Growth > 10% 22.4% Pass
  Total Score   6 out of 10

Source: S&P Capital IQ. Total score = number of passes.

Since we looked at Walgreen last year, the drugstore retailer has picked up two points. With continued dividend growth and improvements on returns on equity, Walgreen is working its way closer to perfection.

Walgreen has made steady progress in growing income over the past decade, even though its share price hasn't advanced much. That's helped push the drugstore retailer down to a point at which its shares look extremely attractive.

Despite share weakness, Walgreen has actually been posting some pretty strong financial results. In its most recent quarter, same-store sales rose 4.4%, beating rivals CVS Caremark (NYSE: CVS  ) and Rite Aid (NYSE: RAD  ) .

But concerns over pharmacy benefits management relationships are weighing down the company right now. Rather than competing against CVS, Walgreen sold off its PBM business to Catalyst Health (Nasdaq: CHSI  ) earlier this year, allowing Walgreen to focus on its retail stores. But an ongoing disagreement with Express Scripts (Nasdaq: ESRX  ) over payment terms led to Walgreen choosing to terminate its contract with Express Scripts as of the beginning of 2012. With Express planning to buy Medco Health Solutions (NYSE: MHS  ) , the fallout from the dispute could be far-reaching and have a big impact on Walgreen's numbers.

For shareholders, Walgreen not only pays a dividend approaching 3% but has also authorized a $2 billion stock buyback earlier this year. Given that drug retail is a low-margin business, it's improbable that Walgreen will ever reach true perfection. But with some help, improving growth numbers is a goal that could be within reach.

Keep searching
No stock is a sure thing, but some stocks are a lot closer to perfect than others. By looking for the perfect stock, you'll go a long way toward improving your investing prowess and learning how to separate the best investments from the rest.

Click here to add Walgreen to My Watchlist, which can find all of our Foolish analysis on it and all your other stocks.

Finding the perfect stock is only one piece of a successful investment strategy. Get the big picture by taking a look at our "13 Steps to Investing Foolishly."

Fool contributor Dan Caplinger doesn't own shares of the companies mentioned. Motley Fool newsletter services have recommended buying shares of Medco Health Solutions. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool has a disclosure policy.

Read/Post Comments (1) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On November 11, 2011, at 12:57 PM, vaderblue wrote:

    Walgreens without express scripts will collaspe.

    The company doesn't pay enough attention to its

    Cost of Sales and poor control of inventory.

    Their policies are choking the store sales. Sales could be much better but corporate need to focus

    on Cost of Sales.

    Inventory wise they probably have a very high write-off of inventory the average investor never


    The waiting time to get prescriptions filled is longer. They just don't have enough staff in these stores to handle the sales volumes. Leading to poor service. This will eventually take a big hit on the financials.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1587892, ~/Articles/ArticleHandler.aspx, 10/21/2016 1:21:34 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,107.09 -55.26 -0.30%
S&P 500 2,137.93 -3.41 -0.16%
NASD 5,249.86 8.02 0.15%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/21/2016 1:05 PM
WBA $80.91 Down -0.11 -0.14%
Walgreens Boots Al… CAPS Rating: ****
CHSI.DL $0.00 Down +0.00 +0.00%
Catalyst Health So… CAPS Rating: ****
CVS $87.32 Up +0.02 +0.02%
CVS Health CAPS Rating: ****
ESRX $69.72 Down -1.32 -1.86%
Express Scripts CAPS Rating: *****
MHS.DL $70.30 Down +0.00 +0.00%
Medco Health Solut… CAPS Rating: *****
RAD $7.01 Down -0.11 -1.48%
Rite Aid CAPS Rating: ****